Health Care & Life Sciences » Biotechnology | RELIEF THERAPEUTICS Holding AG

RELIEF THERAPEUTICS Holding AG | Income Statement

Fiscal year is January-December. All values CHF Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
20,804.10
-
-
16.30
-
565
Cost of Goods Sold (COGS) incl. D&A
28,961.70
7,314.60
79.00
1,029.90
1,063.00
418
Gross Income
8,157.70
7,314.60
79.00
1,013.50
1,063.00
147
SG&A Expense
3,365.00
-
7.50
212.50
182.00
643
EBIT
11,522.70
-
-
1,226.00
1,245.00
502
Unusual Expense
-
-
-
16,743.50
522.00
-
Non Operating Income/Expense
569.90
98.40
-
1.10
27.00
230
Interest Expense
704.00
115.40
-
353.10
107.00
144
Pretax Income
12,490.10
7,331.60
86.50
18,323.70
1,901.00
416
Income Tax
217.90
77.70
-
21.80
986.00
20
Consolidated Net Income
12,272.20
7,253.90
86.50
18,345.50
2,887.00
436
Net Income
12,224.20
7,251.50
86.50
18,345.50
2,887.00
436
Net Income After Extraordinaries
12,224.20
2,101.90
86.50
18,345.50
2,887.00
436
Net Income Available to Common
12,224.20
12,401.10
86.50
18,345.50
2,887.00
436
EPS (Basic)
0.07
0.03
0.00
0.01
0.00
-
Basic Shares Outstanding
171,382.40
475,151.80
586,500.00
1,265,770.70
1,988,024.60
2,050,141.30
EPS (Diluted)
0.07
0.03
0.00
0.01
0.00
-
Diluted Shares Outstanding
171,382.40
475,151.80
586,500.00
1,265,770.70
1,988,024.60
2,050,141.30
EBITDA
9,538.60
2,662.80
-
1,215.10
1,242.00
485
Non-Operating Interest Income
306.50
-
-
-
-
-
Minority Interest Expense
48.00
2.40
-
-
-
-

About RELIEF THERAPEUTICS Holding

View Profile
Address
Avenue de Sécheron 15
Geneva Geneve (Geneva) 1202
Switzerland
Employees -
Website http://www.relieftherapeutics.com
Updated 07/08/2019
RELIEF THERAPEUTICS Holding AG is a clinical stage biotechnology, which engages in the drug development and discovery business. Its products include pipeline, indications, compounds and clinical trials. The company was founded in June 2016 and is headquartered in Geneva, Switzerland.